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Abstract A novel synthetic approach was developed for the construc-
tion of the 1,2,3,4-tetrahydroisoquinoline framework possessing varied
functions. The synthetic strategy was based on oxidative ring opening
of some indene derivatives through their C=C bond, followed by double
reductive amination of the dicarbonyl intermediates with various pri-
mary alkyl- or fluoroalkylamines.
Key words tetrahydroisoquinolines, ring opening, ring closure, reduc-
tion, amination, fluorination
The 1,2,3,4-tetrahydroisoquinoline framework is a com-
monplace and important structural element found in a
number of structural units of numerous natural products.
Many of these natural products, for example, some alka-
loids, exhibit various valuable biological properties. More-
over, several drugs, such as some antidiuretics, antidepres-
sants, hallucinogens, and antihypertensive agents, also con-
tain a tetrahydroisoquinoline core.1 Because of the
importance of products possessing the 1,2,3,4-tetrahy-
droisoquinoline skeleton, many synthetic approaches to the
creation of an isoquinoline or 1,2,3,4-tetrahydroisoquino-
line core have been described.2
As a consequence of their high biological potential, fluo-
rinated organic compounds have generated increasing at-
tention in organic and medicinal chemistry over the past
decade. The replacement of one or more hydrogen atoms by
fluorine in various biomolecules can generate remarkable
changes in their physical, chemical, and biological proper-
ties.3 Fluorine-containing tetrahydroisoquinoline or iso-
quinoline derivatives constitute an important segment in
the family of fluorinated molecules, either as pharmaceuti-
cals or agrochemicals (Figure 1). However, tetrahydroiso-
quinoline derivatives incorporating fluorine in their struc-
ture are not very abundant.4 The synthesis of fluorinated,
fluoroalkylated, or fluoroarylated isoquinoline derivatives
with valuable biological properties continues to be a field of
considerable interest in medicinal and organic chemistry.
Several methods for the creation of monofluorinated, trifluo-
romethylated, or fluoroarylated isoquinolines have been
developed in recent years.4
Figure 1  Some biologically important fluorine-containing isoquinoline 
derivatives.
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l.Because of the high biological importance of 1,2,3,4-tet-
rahydroisoquinoline alkaloids and the increasing relevance
of various organofluorine scaffolds, our goal was to develop
an efficient procedure for accessing various fluorinated
1,2,3,4-tetrahydroisoquinoline derivatives. The novel syn-
thetic route that we developed is based on oxidative ring
opening/ring closing with reductive amination protocol.5
Briefly, it starts from indene or a substituted indene deriva-
tive, and it includes the key steps of olefin-bond cleavage
through dihydroxylation/NaIO4-mediated oxidation and
subsequent cyclization with primary amines through re-
ductive amination.
First, we started with the transformation of unsubsti-
tuted 1H-indene (1). Thus, diol 2,6 derived by OsO4-cata-
lyzed dihydroxylation of 1H-indene (1), was subjected to
ring cleavage with NaIO4 (Scheme 1). The resulting unstable
diformyl intermediate compound I-1 was further trans-
formed, without isolation, with various commercially avail-
able fluorine-containing primary amines to give the target
compounds in two steps. Reductive amination of I-1 with
(2,2-difluoroethyl)amine, (2,2,2-trifluoroethyl)amine, or
(2-fluoroethyl)amine in the presence of NaBH3CN provided,
through cyclization, modest yields of the corresponding tet-
rahydroisoquinoline derivatives 3, 4,7 and 5, containing a
mono-, di-, or trifluoromethyl group, respectively (Scheme
1).8 It is clear from the above results that the yield of the
isoquinoline product decreased on increasing the number
of fluorine atoms in the amine. It should be mentioned that
attempt to carry out the transformation of 2 into the tetra-
hydroisoquinoline derivatives in one-pot manner failed.
The method was further extended to synthesize other
novel fluorine-containing tetrahydroisoquinoline deriva-
tives by starting from diol 2. Oxidative ring opening fol-
lowed by treatment of the resulting dialdehyde I-1 with
various commercially available trifluoromethylated or poly-
fluorinated amines gave the corresponding N-heterocycles
6–9 (Table 1).
Scheme 1 
OH
OH O
O
N CF3
 OsO4/t-BuOH
NMO, H2O, acetone
20 °C, 3 h
20 °C, 1 h
  NaIO4
THF/H2O CF3CH2NH2HCl, EtOH
NaHCO3, NaBH3CN
AcOH, 20 °C, 3 h
1
2 (75%)
I-1
4 (20%, two steps)
N CHF2
3 (31%, two steps)
N CH2F
5 (76%, two steps)
CHF2CH2NH2HCl, EtOH
NaHCO3, NaBH3CN
AcOH, 20 °C, 3 h
CH2FCH2NH2HCl, EtOH
NaHCO3, NaBH3CN
AcOH, 20 °C, 3 h
Table 1  Synthesis of N-Heterocycles 6–9
Starting Compound Fluorinated Amine Product Yield (%)a
6
34
7
24
8
53
9
28
a Yield over two steps.
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l.This synthetic route was further extended by using in-
dene derivatives with substituents on the benzene ring. For
this purpose, we selected 7-bromo-1H-indene (10) as a
model compound, which was transformed into the corre-
sponding diol 11 through cis-dihydroxylation. Oxidative
cleavage of the vicinal diol 11 with NaIO4 in THF–H2O at
room temperature, as in the case of the unsubstituted de-
rivative, gave the corresponding unstable diformyl-substi-
tuted intermediate I-2. Without isolation or characteriza-
tion, this reacted further with (2,2,2-trifluoroethyl)amine
or (2,2-difluoroethyl)amine under reductive conditions in
the presence of NaBH3CN in EtOH at room temperature for
three hours to give the corresponding trifluorinated and di-
fluorinated tetrahydroisoquinoline derivatives 12 and 13,
respectively, through double reductive amination (Scheme 2).
A further extension of this method was attempted with
another substituted indene derivative bearing a substituent
on the five-membered ring moiety. Thus, 2-methyl-1H-in-
dene (14) was selected as a model substrate for the isoquin-
oline ring construction. Dihydroxylation of 14 smoothly
gave diol 15,9 which underwent ring cleavage with NaIO4 to
give the dicarbonyl derivative I-3 (Scheme 3). After workup,
this immediately reacted with (2,2,2-trifluoroethyl)amine
to give the isoquinoline derivative 16, with a newly gener-
ated chiral center, in moderate yield (33%, two steps from
15).
Finally, we attempted to apply the tetrahydroisoquino-
line ring-creation method described above to various non-
fluorinated reactants. The generality of the developed
method was demonstrated by using three different primary
amines: ethylamine (as the nonfluorinated counterpart of
the previously used mono-, di-, or trifluoroethylamines),
butylamine, and benzylamine. Cyclization of the diformyl
intermediate I-1 (derived from diol 2) by reaction with
these amines gave modest yields of the corresponding N-
substituted tetrahydroisoquinoline derivatives 17,10 18,11
and 19,12 respectively (Scheme 4). The highest yield was ob-
tained from benzylamine (69%, two steps).
In conclusion, convenient, and efficient procedure has
been developed for the construction of the 1,2,3,4-tetrahy-
droisoquinoline framework with various fluorine-contain-
ing or nonfluorinated substituents. The method is based on
oxidative ring cleavage of the olefinic bond of 1H-indene or
a substituted indene derivatives, followed by reductive ring
closure of the diformyl intermediate with an amine. Exten-
sions of this method to the preparation of novel substituted
tetrahydroquinoline derivatives are currently being investi-
gated in our laboratory.
Scheme 2 
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